Synaptic plasticity as a therapeutic target in the treatment of autism-related single-gene disorders

Keyphrases

• Therapeutic Target 100%
• Autism Spectrum Disorder 100%
• Synaptic Plasticity 100%
• Autism Treatment 100%
• Single Gene Disorders 100%
• Molecular Mechanism 50%
• Cellular Mechanisms 50%
• Mouse Model 25%
• Disease Pathology 25%
• Murine Model 25%
• Monogenic 25%
• Comorbidity 25%
• Transgenic Mouse Model 25%
• Therapeutic Intervention 25%
• Intellectual Disability 25%
• Recent Advances 25%
• Positive Allosteric Modulator 25%
• Synaptic Remodeling 25%
• Communication Difficulties 25%
• Epilepsy 25%
• Transgenic Technology 25%
• Therapeutic Strategies 25%
• Pervasive Developmental Disorder 25%
• Social Deficits 25%
• Stereotypic Behavior 25%
• Synaptic Transmission 25%
• Valuable Insight 25%
• Underlying Disease 25%
• Pharmacological Strategies 25%
• Autism Spectrum 25%
• Cognitive Delay 25%
• Repetitive Behavior 25%
• Negative Allosteric Modulator 25%
• MGlu5 Receptor 25%
• Autism Mouse Model 25%
• Pharmacological Modulation 25%
• Hippocampal Plasticity 25%

Biochemistry, Genetics and Molecular Biology

• Nerve Cell Plasticity 100%
• Single Gene Disorder 100%
• Mouse Model 50%
• Genetics 50%
• Transgenics 50%
• Animal Model 50%
• Synaptic Transmission 50%
• Transgenic Organism 50%
• Comorbidity 50%

Neuroscience

• Pervasive Developmental Disorder 100%
• Synaptic Plasticity 100%
• Synaptic Transmission 20%
• Compulsive Behavior 20%
• Stereotypy 20%
• Receptor 20%
• Comorbidity 20%